Conclusions The Myopia Index reflects the real status of fundus microstructures through fundus microstructures, with a particular focus on the choroid. The Myopia Index demonstrates good predictive ...

Nearsightedness can range from mild to legal blindness. It tends to progress as you age, but prevention is available. Share on Pinterest Also known as known as myopia, nearsightendess refers to a ...

SAN RAMON, Calif., October 6, 2021—CooperVision’s SightGlass Vision Business has revealed two-year clinical study data for its Diffusion Optics Technology ™ §, which is specifically designed to slow ...

The United States is fast becoming a nearsighted nation: More than 40% of Americans have myopia, and the number is climbing fast, especially for children. Experts aren’t sure why, but they believe ...

In September 2025, a first-of-its-kind medical device — glasses — to prevent pediatric myopia was granted marketing authorization by the FDA. In a 2-year randomized controlled trial, the Essilor ...

According to a secondary analysis of the 24- Month Myopia Outcome Study of Atropine in Children (MOSAIC) trial, 0.05% atropine eye drops were more effective in controlling myopia progression and axial ...

Child eye test and eye exam. Little girl having eye check-up, with phoropter. Doctor performs eye test for child. This story is part of a series on the current progression in Regenerative Medicine.

Myopia control is not just for children with progressive myopia; it can be applied to adults and pre-myopes as well, according to a speaker at Vision Expo.“[There are] two things I want you to be ...

Use of low-dose atropine eyedrops (concentration 0.01%) was no better than placebo at slowing myopia (nearsightedness) progression and elongation of the eye among children treated for two years, ...

An increase in myopia progression was observed among Chicago-area children early in the COVID-19 pandemic, reported researchers, who suggested that closure of schools and cancelling of activities may ...

A study that focused on children aged 5 to 12 years who lived in the United States found no difference between atropine 0.01% and placebo in treating myopia progression. Atropine 0.01% was no more ...

In late September the U.S. Food and Drug Administration made an announcement that has the potential to positively impact tens of millions of kids for the rest of their lives. That’s because the FDA ...